GSK Pharma Q1 profit rises 16% to Rs 237 crore as revenue reaches Rs 938 crore
GSK Pharma reported a 15.7% year-on-year rise in consolidated net profit for the quarter ended June, supported by 16.5% revenue growth. EBITDA rose 17.6% to Rs 295 crore and margin improved to 31.5%.
GSK Pharma’s first-quarter consolidated profit rose 15.7% year-on-year to Rs 237 crore as revenue climbed 16.5% to Rs 938 crore. EBITDA increased 17.6% to Rs 295 crore, with margin improving to 31.5%.
Why this matters
No related recent GSK Pharma signals are listed, making the June-quarter results a current benchmark for the brand's revenue growth, profitability and margin performance.
Retail-company signals are accelerating, up 227950% QoQ.